Literature DB >> 28466417

Components of quality of life in a sample of patients with lupus: a confirmatory factor analysis and Rasch modeling of the LupusQoL.

Ana-Belén Meseguer-Henarejos1, Juan-José Gascón-Cánovas2, José-Antonio López-Pina3.   

Abstract

The objective of this study was to test different exploratory solutions to the LupusQoL scale in a sample of Spanish patients with SLE using confirmatory factor analysis (CFA) and Rasch modeling, as well as to estimate the convergent validity. The χ 2 test, RMSEA, CFI, and TLI were used to test the fit of the different exploratory structures with CFA. To estimate the parameters in the dimensions found, a rating scale Rasch multidimensional random coefficient multinomial logit model was used. The reliability of the scores was obtained with coefficient alpha and coefficient omega. The convergent validity was calculated using Spearman's rho. Four hundred and fifty patients participated but complete data were available for 223 subjects. The original version (UK) and the French version obtained the best fit, showing that the proposed original structure was the best solution for the structure of the LupusQoL scale in the Spanish sample. The multidimensional solution of eight dimensions was adequate, but item 8 in physical health, item 16 in intimate relations, and items 29 and 30 obtained mean squares >1.6. Internal consistency and coefficient omega of the scores in the eight domains were higher. The Spanish version of LupusQoL correlated strongly with the corresponding SLAQ, EQ5D analogic scale, and EQ5D domain. This analysis confirmed the structure of eight dimensions of the original version in patients with SLE.

Entities:  

Keywords:  Confirmatory factor analysis; Multidimensional Rasch modeling; Quality of life; Systemic lupus erythematosus

Mesh:

Year:  2017        PMID: 28466417     DOI: 10.1007/s10067-017-3649-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  29 in total

1.  Dimensions of fatigue in systemic lupus erythematosus: relationship to disease status and behavioral and psychosocial factors.

Authors:  Deborah Da Costa; Maria Dritsa; Sasha Bernatsky; Christian Pineau; Henri A Ménard; Kaberi Dasgupta; Anahita Keschani; Natalie Rippen; Ann E Clarke
Journal:  J Rheumatol       Date:  2006-06-01       Impact factor: 4.666

2.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

3.  Mortality and causes of death in systemic lupus erythematosus.

Authors:  J Trager; M M Ward
Journal:  Curr Opin Rheumatol       Date:  2001-09       Impact factor: 5.006

4.  Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies.

Authors:  E W Karlson; L H Daltroy; C Rivest; R Ramsey-Goldman; E A Wright; A J Partridge; M H Liang; P R Fortin
Journal:  Lupus       Date:  2003       Impact factor: 2.911

Review 5.  Experiences and perspectives of adults living with systemic lupus erythematosus: thematic synthesis of qualitative studies.

Authors:  Bernadet Sutanto; Davinder Singh-Grewal; H Patrick McNeil; Sean O'Neill; Jonathan C Craig; Julie Jones; Allison Tong
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-11       Impact factor: 4.794

6.  Drivers of cost and health-related quality of life in patients with systemic lupus erythematosus (SLE): a Swedish nationwide study based on patient reports.

Authors:  C Bexelius; K Wachtmeister; P Skare; L Jönsson; R van Vollenhoven
Journal:  Lupus       Date:  2013-06-11       Impact factor: 2.911

7.  Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Munther A Khamashta; Josep Font; Gian Domenico Sebastiani; Antonio Gil; Paz Lavilla; Juan Carlos Mejía; A Olcay Aydintug; Hanna Chwalinska-Sadowska; Enrique de Ramón; Antonio Fernández-Nebro; Mauro Galeazzi; Merete Valen; Alessandro Mathieu; Frédéric Houssiau; Natividad Caro; Paula Alba; Manuel Ramos-Casals; Miguel Ingelmo; Graham R V Hughes
Journal:  Medicine (Baltimore)       Date:  2003-09       Impact factor: 1.889

8.  Flare, persistently active disease, and serologically active clinically quiescent disease in systemic lupus erythematosus: a 2-year follow-up study.

Authors:  Fabrizio Conti; Fulvia Ceccarelli; Carlo Perricone; Francesca Miranda; Simona Truglia; Laura Massaro; Viviana Antonella Pacucci; Virginia Conti; Izabella Bartosiewicz; Francesca Romana Spinelli; Cristiano Alessandri; Guido Valesini
Journal:  PLoS One       Date:  2012-09-21       Impact factor: 3.240

9.  Linguistic Validation of the LupusQoL for the Assessment of Quality of Life in Iranian Patients with Systemic Lupus Erythematosus.

Authors:  Naeimehossadat Hosseini; Zahra Sayed Bonakdar; Ali Gholamrezaei; Leila Mirbagher
Journal:  Int J Rheumatol       Date:  2014-09-09

10.  Validity of LupusQoL-China for the assessment of health related quality of life in Chinese patients with systemic lupus erythematosus.

Authors:  Su-li Wang; Bin Wu; Lin Leng; Richard Bucala; Liang-jing Lu
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

View more
  1 in total

1.  Measurement properties of selected patient-reported outcome measures for use in randomised controlled trials in patients with systemic lupus erythematosus: a systematic review.

Authors:  Vibeke Strand; Lee S Simon; Alexa Simon Meara; Zahi Touma
Journal:  Lupus Sci Med       Date:  2020-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.